Contact Us
Stamford Daily Voice serves Stamford, CT

Menu

Stamford Daily Voice serves Stamford, CT

Nearby Towns

business

Alliance For Cancer Gene Therapy In Stamford Chooses New CEO/President

John Walter, right, is the new chief executive officer and president of Alliance for Cancer Gene Therapy. Walter will lead the organization and be the successor to the co-founder and president, Barbara Netter, left.
John Walter, right, is the new chief executive officer and president of Alliance for Cancer Gene Therapy. Walter will lead the organization and be the successor to the co-founder and president, Barbara Netter, left. Photo Credit: Contributed

STAMFORD, Conn. -- The Alliance for Cancer Gene Therapy (ACGT) in Stamford has brought on John Walter as its new chief executive officer and president. Walter will lead the organization and be the successor to the co-founder and president, Barbara Netter.

Walter is the former chief executive officer of the Leukemia and Lymphoma Society. At ACGT, he will continue to support scientific cancer gene/cell and immunotherapy research.

Netter co-founded ACGT with her husband, Edward in 2001 after their daughter-in-law’s death from breast cancer.

“Edward Netter was the primary champion of gene therapy and what Edward envisioned is coming to pass,” noted Netter, speaking about her late husband. “Prior to 2001, there were no gene therapy treatments. Now we are seeing gene therapy success with commercialization. Several companies are finding gene therapy as a significant platform for investment.

"Edward’s vision was ahead of his time. He passed away just six months before Dr. Carl June of the University of Pennsylvania and an ACGT grantee made his announcement in the New England Journal of Medicine that his discovery of using T-Cell Cart 19 successfully treated leukemia," she added.

“I am thrilled to be coming on board to lead the vision and direction of ACGT,” said Walter. “ACGT’s focus in cell, gene and immunotherapy for uncovering treatments for all cancer, as well as the remarkable people that make up the board and scientific advisory council, were major considerations as to why I came on board. This is truly an incredible time to be working in cancer research with significant breakthroughs on the way for patients.”

Prior to joining ACGT, Walter led The Leukemia & Lymphoma Society and was there for 18 years in several positions from chief executive officer, chief operating officer, executive vice president of Strategic Alliances & Business Development, chief financial officer and senior vice president of Finance and Information Technology.

Prior to his time with The Leukemia & Lymphoma Society, he was the director of Financial Planning and Budgeting with the March of Dimes where he was responsible for managing the March of Dimes $200 million budget.

He holds a bachelor of science degree in economics from Southern Connecticut State University.

Welcome to

Stamford Daily Voice!

This is a one time message inviting you to keep in touch

Get important news about your town as it happens.